These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24626310)

  • 1. Interruption of vector transmission by native vectors and "the art of the possible".
    Salvatella R; Irabedra P; Castellanos LG
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):122-5. PubMed ID: 24626310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Certifying the interruption of Chagas disease transmission by native vectors: cui bono?
    Abad-Franch F; Diotaiuti L; Gurgel-Gonçalves R; Gürtler RE
    Mem Inst Oswaldo Cruz; 2013 Apr; 108(2):251-4. PubMed ID: 23579810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On bugs and bias: improving Chagas disease control assessment.
    Abad-Franch F; Diotaiuti L; Gurgel-Gonçalves R; Gürtler RE
    Mem Inst Oswaldo Cruz; 2014 Feb; 109(1):125-30. PubMed ID: 24809110
    [No Abstract]   [Full Text] [Related]  

  • 4. Control measures for Chagas disease.
    Cruz-Pacheco G; Esteva L; Vargas C
    Math Biosci; 2012 May; 237(1-2):49-60. PubMed ID: 22450034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries.
    Moncayo A
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):577-91. PubMed ID: 12973523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of vector-borne transmission of Chagas disease.
    Silveira A; Vinhaes M
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():405-11. PubMed ID: 10677766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of Chagas disease vectors.
    Ramsey JM; Schofield CJ
    Salud Publica Mex; 2003; 45(2):123-8. PubMed ID: 12736992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sylvatic triatominae: a new challenge in vector control transmission.
    Guhl F; Pinto N; Aguilera G
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():71-5. PubMed ID: 19753461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The control of Latin American trypanosomiasis.
    Marsden PD
    Rev Soc Bras Med Trop; 1997; 30(6):521-7. PubMed ID: 9463200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial symbionts of the triatominae and their potential use in control of Chagas disease transmission.
    Beard CB; Cordon-Rosales C; Durvasula RV
    Annu Rev Entomol; 2002; 47():123-41. PubMed ID: 11729071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current situation of Chagas disease in Central America.
    Ponce C
    Mem Inst Oswaldo Cruz; 2007 Oct; 102 Suppl 1():41-4. PubMed ID: 17713679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fenitrothion (OMS-43) in the control of Triatoma infestans, the vector of Chagas disease in Argentina].
    Cichero JA; Gualtieri JA; Vaez R; Rios CH; Carcavallo RU
    Ann Soc Belg Med Trop; 1985; 65 Suppl 1():181-5. PubMed ID: 3931583
    [No Abstract]   [Full Text] [Related]  

  • 13. [Triatominae and Cactaceae: a risk for the transmission of the American trypanosomiasis in the peridomicilary space (Northeast Brazil)].
    Emperaire L; Romaña CA
    Parasite; 2006 Jun; 13(2):171-8. PubMed ID: 16800127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of Chagas disease transmission in the Andean countries: Colombia.
    Guhl F; Vallejo GA
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():413-5. PubMed ID: 10677767
    [No Abstract]   [Full Text] [Related]  

  • 15. Elimination of the vectorial transmission of Chagas disease in Central American countries: Honduras.
    Ponce C
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():417-8. PubMed ID: 10677768
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of Chagas disease control in Latin America: a review.
    Dias JC; Silveira AC; Schofield CJ
    Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):603-12. PubMed ID: 12219120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Towards the elimination of the transmission of Trypanosoma cruzi in Honduras and Central American countries].
    Ponce C
    Medicina (B Aires); 1999; 59 Suppl 2():117-9. PubMed ID: 10668252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andean subregional Chagas disease area and the Andean initiative of Chagas disease.
    Salvatella R
    Mem Inst Oswaldo Cruz; 2007 Oct; 102 Suppl 1():39-40. PubMed ID: 17906804
    [No Abstract]   [Full Text] [Related]  

  • 19. Complementary Paths to Chagas Disease Elimination: The Impact of Combining Vector Control With Etiological Treatment.
    Cucunubá ZM; Nouvellet P; Peterson JK; Bartsch SM; Lee BY; Dobson AP; Basáñez MG
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S293-S300. PubMed ID: 29860294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current situation with chagas disease vector control in the Americas].
    Silveira AC
    Cad Saude Publica; 2000; 16 Suppl 2():35-42. PubMed ID: 11119318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.